Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines

Gastric cancer (GC) is a major health concern worldwide, presenting a complex pathophysiology that has hindered many therapeutic efforts so far. In this context, purinergic signaling emerges as a promising pathway for intervention due to its known role in cancer cell proliferation and migration. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyna-Jeldes, Mauricio, De la Fuente-Ortega, Erwin, Cerda, Daniela, Velázquez-Miranda, Erandi, Pinto, Katherine, Vázquez-Cuevas, Francisco G., Coddou, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398939/
https://www.ncbi.nlm.nih.gov/pubmed/34452195
http://dx.doi.org/10.3390/pharmaceutics13081234
_version_ 1783744957887021056
author Reyna-Jeldes, Mauricio
De la Fuente-Ortega, Erwin
Cerda, Daniela
Velázquez-Miranda, Erandi
Pinto, Katherine
Vázquez-Cuevas, Francisco G.
Coddou, Claudio
author_facet Reyna-Jeldes, Mauricio
De la Fuente-Ortega, Erwin
Cerda, Daniela
Velázquez-Miranda, Erandi
Pinto, Katherine
Vázquez-Cuevas, Francisco G.
Coddou, Claudio
author_sort Reyna-Jeldes, Mauricio
collection PubMed
description Gastric cancer (GC) is a major health concern worldwide, presenting a complex pathophysiology that has hindered many therapeutic efforts so far. In this context, purinergic signaling emerges as a promising pathway for intervention due to its known role in cancer cell proliferation and migration. In this work, we explored in more detail the role of purinergic signaling in GC with several experimental approaches. First, we measured extracellular ATP concentrations on GC-derived cell lines (AGS, MKN-45, and MKN-74), finding higher levels of extracellular ATP than those obtained for the non-tumoral gastric cell line GES-1. Next, we established the P2Y2 and P2X4 receptors (P2Y2R and P2X4R) expression profile on these cells and evaluated their role on cell proliferation and migration after applying overexpression and knockdown strategies. In general, a P2Y2R overexpression and P2X4R downregulation pattern were observed on GC cell lines, and when these patterns were modified, concomitant changes in cell viability were observed. These modifications on gene expression also modified transepithelial electrical resistance (TEER), showing that higher P2Y2R levels decreased TEER, and high P2X4R expression had the opposite effect, suggesting that P2Y2R and P2X4R activation could promote and suppress epithelial-mesenchymal transition (EMT), respectively. These effects were confirmed after treating AGS cells with UTP, a P2Y2R-agonist that modified the expression patterns towards mesenchymal markers. To further characterize the effects of P2Y2R activation on EMT, we used cDNA microarrays and observed that UTP induced important transcriptional changes on several cell processes like cell proliferation induction, apoptosis inhibition, cell differentiation induction, and cell adhesion reduction. These results suggest that purinergic signaling plays a complex role in GC pathophysiology, and changes in purinergic balance can trigger tumorigenesis in non-tumoral gastric cells.
format Online
Article
Text
id pubmed-8398939
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83989392021-08-29 Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines Reyna-Jeldes, Mauricio De la Fuente-Ortega, Erwin Cerda, Daniela Velázquez-Miranda, Erandi Pinto, Katherine Vázquez-Cuevas, Francisco G. Coddou, Claudio Pharmaceutics Article Gastric cancer (GC) is a major health concern worldwide, presenting a complex pathophysiology that has hindered many therapeutic efforts so far. In this context, purinergic signaling emerges as a promising pathway for intervention due to its known role in cancer cell proliferation and migration. In this work, we explored in more detail the role of purinergic signaling in GC with several experimental approaches. First, we measured extracellular ATP concentrations on GC-derived cell lines (AGS, MKN-45, and MKN-74), finding higher levels of extracellular ATP than those obtained for the non-tumoral gastric cell line GES-1. Next, we established the P2Y2 and P2X4 receptors (P2Y2R and P2X4R) expression profile on these cells and evaluated their role on cell proliferation and migration after applying overexpression and knockdown strategies. In general, a P2Y2R overexpression and P2X4R downregulation pattern were observed on GC cell lines, and when these patterns were modified, concomitant changes in cell viability were observed. These modifications on gene expression also modified transepithelial electrical resistance (TEER), showing that higher P2Y2R levels decreased TEER, and high P2X4R expression had the opposite effect, suggesting that P2Y2R and P2X4R activation could promote and suppress epithelial-mesenchymal transition (EMT), respectively. These effects were confirmed after treating AGS cells with UTP, a P2Y2R-agonist that modified the expression patterns towards mesenchymal markers. To further characterize the effects of P2Y2R activation on EMT, we used cDNA microarrays and observed that UTP induced important transcriptional changes on several cell processes like cell proliferation induction, apoptosis inhibition, cell differentiation induction, and cell adhesion reduction. These results suggest that purinergic signaling plays a complex role in GC pathophysiology, and changes in purinergic balance can trigger tumorigenesis in non-tumoral gastric cells. MDPI 2021-08-11 /pmc/articles/PMC8398939/ /pubmed/34452195 http://dx.doi.org/10.3390/pharmaceutics13081234 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reyna-Jeldes, Mauricio
De la Fuente-Ortega, Erwin
Cerda, Daniela
Velázquez-Miranda, Erandi
Pinto, Katherine
Vázquez-Cuevas, Francisco G.
Coddou, Claudio
Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines
title Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines
title_full Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines
title_fullStr Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines
title_full_unstemmed Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines
title_short Purinergic P2Y2 and P2X4 Receptors Are Involved in the Epithelial-Mesenchymal Transition and Metastatic Potential of Gastric Cancer Derived Cell Lines
title_sort purinergic p2y2 and p2x4 receptors are involved in the epithelial-mesenchymal transition and metastatic potential of gastric cancer derived cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398939/
https://www.ncbi.nlm.nih.gov/pubmed/34452195
http://dx.doi.org/10.3390/pharmaceutics13081234
work_keys_str_mv AT reynajeldesmauricio purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines
AT delafuenteortegaerwin purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines
AT cerdadaniela purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines
AT velazquezmirandaerandi purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines
AT pintokatherine purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines
AT vazquezcuevasfranciscog purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines
AT coddouclaudio purinergicp2y2andp2x4receptorsareinvolvedintheepithelialmesenchymaltransitionandmetastaticpotentialofgastriccancerderivedcelllines